Medi Aimer Pharmaceutical Private Limited
About Medi Aimer Pharmaceutical Private Limited
Data last updated:
Medi Aimer Pharmaceutical Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 May 2023.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U47721UP2023PTC181936. Its GSTIN is 09AAQCM8568A1ZZ (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rahul Srivastava and Prabhat Ranjan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ghaziabad, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.9 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹25,317 (net margin 1.7%) and EBITDA of ₹34,359 (EBITDA margin 2.3%).
As per MCA filings, the company has open charges of ₹5 Lakh on record.
Company details
Contact details
Medi Aimer Pharmaceutical Private Limited's registered office is in Ghaziabad, Uttar Pradesh.
- Registered AddressFlat No.101 Block – 3, Express Garden Vaibhav Khand, Ghaziabad, Uttar Pradesh, India – 201014
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medi Aimer Pharmaceutical is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Medi Aimer Pharmaceutical Private Limited, buy the company report.
Financials of Medi Aimer Pharmaceutical Private Limited
FY 2025 filings availableMedi Aimer Pharmaceutical Private Limited reported revenue of ₹14.9 Lakh (up 173% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 173% in the latest year. EBITDA rose 47% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹34,359 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹25,317 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.3% | |
| Net Profit Margin | 1.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Medi Aimer Pharmaceutical Private Limited, buy the company report.
Board of directors of Medi Aimer Pharmaceutical Private Limited
Medi Aimer Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Srivastava | Director | 11 May 2023 | 3 Years 5 Months | Current |
| Prabhat Ranjan | Director | 11 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Medi Aimer Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sadhan Crop Sciences Private Limited | ₹15.32 Lakh (FY 2025) | Maval, Maharashtra, India | ||||
| Risana Pharma Private Limited | ₹15.25 Lakh (FY 2025) | 172.0% | Indore, Madhya Pradesh, India | |||
| JDSK Shine Private Limited | ₹15.22 Lakh (FY 2024) | 3.0% | Chandrapur, Maharashtra, India | |||
| SGM Industries (India) Private Limited | ₹15 Lakh (FY 2024) | -57.0% | Pune, Maharashtra, India | |||
| United Pharmatech (India) Private Limited | ₹15 Lakh (FY 2024) | 4935.0% | New Delhi, Delhi, India | |||
| Medi Aimer Pharmaceutical Private Limitedthis company | ₹14.9 Lakh (FY 2025) | ₹25,317 | 1.7% | 173.0% | Ghaziabad, Uttar Pradesh, India | |
| Green Bharat Chemical Private Limited | ₹14.76 Lakh (FY 2025) | Rajkot, Gujarat, India | ||||
| Mirva Chemicals Private Limited | ₹14.76 Lakh (FY 2025) | Surat, Gujarat, India | ||||
| Upgrace Private Limited | ₹14.69 Lakh (FY 2024) | Pune, Maharashtra, India | ||||
| Ascendum Pharma Private Limited | ₹14.67 Lakh (FY 2024) | 196.0% | Nagpur, Maharashtra, India | |||
| Finoclean Specialities Private Limited | ₹14.59 Lakh (FY 2025) | 569.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Medi Aimer Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Nov 2024 | 101016492 | State Bank of India | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medi Aimer Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medi Aimer Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medi Aimer Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAQCM8568A1ZZ | Uttar Pradesh | Active | 06 Jun 2023 |
To see the full GST registrations and return filing status of Medi Aimer Pharmaceutical Private Limited, buy the company report.
Recent activity
Medi Aimer Pharmaceutical Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Prabhat Ranjan was appointed as Director on 11 May 2023.
Frequently asked questions
Medi Aimer Pharmaceutical is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 May 2023 (3+ years old) and is registered under CIN U47721UP2023PTC181936.
Medi Aimer Pharmaceutical has 2 current directors:
- Rahul Srivastava - Director
- Prabhat Ranjan - Director
The latest financial statements of Medi Aimer Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Medi Aimer Pharmaceutical is 09AAQCM8568A1ZZ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Medi Aimer Pharmaceutical is U47721UP2023PTC181936. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medi Aimer Pharmaceutical was incorporated on 11 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Medi Aimer Pharmaceutical by revenue are Sadhan Crop Sciences Private Limited, Risana Pharma Private Limited, JDSK Shine Private Limited, SGM Industries (India) Private Limited, United Pharmatech (India) Private Limited and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Prabhat Ranjan was appointed as Director on 11 May 2023. Rahul Srivastava was appointed as Director on 11 May 2023.
The registered office of Medi Aimer Pharmaceutical is at Flat No.101 Block – 3, Express Garden Vaibhav Khand, Ghaziabad, Uttar Pradesh, India – 201014.
Medi Aimer Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Medi Aimer Pharmaceutical has open charges of ₹5 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
